| C-(4,6-Dichloro-pyridin-2-yl)-MethylaMine |
1060815-16-8 |
1060815-16-8 |
| Imazameth |
甲基咪草烟 |
104098-48-8 |
| (S)-(-)-7[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,23,3tetrahydro-1,1spirobiindane, min. 97% (Sa,S)-DTB-Bn-SIPHOX |
(S) - ( - )-7'-〔4(S) - (苄基)恶唑-2 - 基]-7-二(3,5 - 二 - 叔丁基苯基)膦基-2,2',3,3'-四氢-1,1螺二氢茚 |
1040274-10-9 |
| GLYCYL-D-VALINE |
甘氨酰-D-缬氨酸 |
10521-49-0 |
| CINNAMYL FORMATE |
甲酸桂酯 |
104-65-4 |
| 1H-PYRROLO[3,2-C]PYRIDINE-4-CARBOXYLIC ACID |
5-AZAINDOLE-4-CARBOXYLIC ACID |
1040682-84-5 |
| 1H-Pyrazole-1-ethanol, β,β-diMethyl-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl- |
1H-Pyrazole-1-ethanol, β,β-diMethyl-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl- |
1040377-18-1 |
| BenzeneethanaMine, 4-phenoxy-, hydrochloride |
2-(4 -苯氧苯基)乙胺盐酸盐 |
106272-17-7 |
| ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS-LEU-VAL-ILE-HIS-ASN |
ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS-LEU-VAL-ILE-HIS-ASN |
104180-23-6 |
| 3-BROMO-5-CYCLOPROPYLPYRIDINE |
3-溴-5-环丙基吡啶 |
1044210-57-2 |
| 2-{2-[(2R,5R)-2,5-dimethyl-1-phospholano]phenyl}1,3-dioxolane, min. 97% |
(2R,5R)-1-(2-(1,3-二氧戊环-2-基)苯基)-2,5-二甲基磷杂环戊烷 |
1044256-04-3 |
| (3-Bromo-4-methyl-phenyl)-acetic acid |
(3-Bromo-4-methyl-phenyl)-acetic acid |
1053661-17-8 |
| 7-Epitaxol |
7-表紫杉醇 |
105454-04-4 |
| 2-tert-butyl-4,6-dichloropyrimidine |
2-(叔丁基)-4,6-二氯嘧啶 |
1044771-51-8 |
| 2-[2-(2-AMINO-9H-PURIN-9-YL)ETHYL]-1,3-PROPANEDIOL |
泛昔洛韦USP RC A |
104227-86-3 |
| Etrolizumab |
ETROLIZUMAB ( 依曲利组单抗 ) |
1044758-60-2 |
| (2S,4R)-4-(4-broMobenzyl)pyrrolidine-2-carboxylic acid |
反-4-(4-溴苄基)-L-脯氨酸 |
1049978-43-9 |
| ALPHA-MSH |
AC-SER-TYR-SER-MET-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL: AC-SYSMEHFRWGKPV |
10466-28-1 |
| 2-chloro-3-methylbenzenemethanamine |
(2-氯-3-甲基苯基)甲胺 |
1044256-78-1 |
| 3-(6-BROMOPYRIDIN-2-YL)-6-CHLOROIMIDAZO[1,2-A]PYRIDINE |
3-(6-溴吡啶-2-基)-6-氯咪唑并[1,2-A]吡啶 |
1044733-65-4 |
